Filing Details
- Accession Number:
- 0001209191-14-051167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-07 17:09:28
- Reporting Period:
- 2014-08-05
- Filing Date:
- 2014-08-07
- Accepted Time:
- 2014-08-07 17:09:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206199 | G Daniel Welch | 3280 Bayshore Blvd Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-05 | 125,100 | $8.73 | 219,302 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-08-05 | 21,025 | $10.10 | 240,327 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-05 | 146,125 | $44.95 | 94,202 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-08-07 | 24,900 | $8.73 | 119,102 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-07 | 24,900 | $45.17 | 94,202 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock options (right to buy) | Disposition | 2014-08-05 | 125,100 | $0.00 | 125,100 | $8.73 |
Common Stock | Stock options (right to buy) | Disposition | 2014-08-05 | 21,025 | $0.00 | 21,025 | $10.10 |
Common Stock | Stock options (right to buy) | Disposition | 2014-08-07 | 24,900 | $0.00 | 24,900 | $8.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,900 | 2020-06-07 | No | 4 | M | Direct | |
128,975 | 2022-06-03 | No | 4 | M | Direct | |
0 | 2020-06-07 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $44.26 to $45.78 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $45.00 to $45.58 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exercisable.